Heme oxygenase in the regulation of vascular biology: From molecular mechanisms to therapeutic opportunities

Antioxidants and Redox Signaling

Volumn 14, Issue 1, 2011, Pages 137-167

  Kim, Young Myeong ^a   Pae, Hyun Ock ^b   Park, Jeong Euy ^c   Lee, Yong Chul ^d   Woo, Je Moon ^e   Kim, Nam Ho ^f   Choi, Yoon Kyung ^a   Lee, Bok Soo ^c   Kim, So Ri ^d   Chung, Hun Taeg ^g  

^a Kangwon National University   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

^e Ulsan University College of Medicine   (South Korea)

^f Wonkwang University Hospital   (South Korea)

^g University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BILIVERDIN; CARBON MONOXIDE; CHEMOKINE; CYTOKINE; FERRITIN; FERROUS ION; HEAT SHOCK PROTEIN; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR BACH1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOLOGY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CATABOLISM; CELL GROWTH; DIABETES MELLITUS; ENDOTHELIUM CELL; GENE EXPRESSION; HEART DEATH; HEART INFARCTION; HEMOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIA; MACROPHAGE; MOLECULAR MECHANICS; MUSCLE CELL; OBSTRUCTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; STROKE; VASCULAR DISEASE; VASCULITIS;

ANIMALS; CARDIOVASCULAR DISEASES; HEME OXYGENASE (DECYCLIZING); HUMANS; OXIDATIVE STRESS; VASCULITIS;

EID: 78649477021     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3153     Document Type: Review

References (300)

1. Abraham NG and Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127, 2008.
2. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, and Wolin M. Heme oxyge-nase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93: 507-514, 2003.
3. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li Volti G, Goodman AI, and Kappas A. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287: H2468-H2477, 2004.
4. Abraham NG, Tsenovoy PL, McClung J, and Drummond GS. Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des 14: 412-421, 2008.
5. Abuarqoub H, Foresti R, Green CJ, and Motterlini R. Heme oxygenase-1 mediates the anti-inflammatory actions of 2'-hydroxychalcone in RAW 264.7 murine macrophages. Am J Physiol Cell Physiol 290: C1092-C1099, 2006.
6. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR, and Ohno M. Heme oxygenase-1 is upre-gulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35: 800-806, 2000.
7. Alam J and Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol 36: 166-174, 2007.
8. Alam J and Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 267: 21894-21900, 1992.
9. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, and Mason JC. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Hae-most 5: 2537-2546, 2007.
10. Ali F, Zakkar M, Karu K, Lidington EA, Hamdulay SS, Boyle JJ, Zloh M, Bauer A, Haskard DO, Evans PC, and Mason JC. Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothe-lium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem 284: 18882-18892, 2009.
11. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, and Kupiec-Weglinski JW. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia=reperfusion injury. J Clin Investig 104: 1631-1639, 1999.
12. Anwar AA, Li FY, Leake DS, Ishii T, Mann GE, and Siow RC. Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radic Biol Med 39: 227-236, 2005.
13. Ashino T, Yamanaka R, Yamamoto M, Shimokawa H, Se-kikawa K, Iwakura Y, Shioda S, Numazawa S, and Yoshida T. Negative feedback regulation of lipopolysaccharide-induced inducible nitric oxide synthase gene expression by heme oxygenase-1 induction in macrophages. Mol Immunol 45: 2106-2115, 2008.
14. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, and Penn MS. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703, 2003.
15. Bach FH. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J 19: 1216-1219, 2005.
16. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective anti-oxidant strategem of endothelium. J Biol Chem 267: 18148-18153, 1992.
17. Balla G, Vercellotti G, Muller-Eberhard U, Eaton JW, and Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64: 648-655, 1991.
18. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, and Vercellotti GM. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9289, 1993.
19. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, and Balla G. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 9: 1-19, 2007.
20. Baranano DE, Rao M, Ferris CD and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
21. Belcher JD, Beckman JD, Balla G, Balla J, and Vercellotti G. Heme degradation and vascular injury. Antioxid Redox Signal 12: 233-248, 2010.
22. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, and Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116: 808-816, 2006.
23. Bellner L, Martinelli L, Halilovic A, Patil K, Puri N, Dunn MW, Regan RF, and Schwartzman ML. Heme oxygenase-2 deletion causes endothelial cell activation marked by oxi-dative stress, inflammation, and angiogenesis. J Pharmacol Exp Ther 331: 925-932, 2009.
24. Berendji-Grun D, Kolb-Bachofen V, and Kroncke KD. Nitric oxide inhibits endothelial IL-1beta-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activity. Mol Med 7: 748-754, 2001.
25. Berliner JA and Heinecke JW. The role of oxidized lipopro-teins in atherogenesis. Free Radic Biol Med 20: 707-727, 1996.
26. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, and Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor ca-chectin. Nature 316: 552-554, 1985.
27. Bilban M, Haschemi A, Wegiel B, Chin BY, Wagner O, and Otterbein LE. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 86: 267-279, 2008.
28. Blankenberg S, Barbaux S, and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170: 191-203, 2003.
29. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, and Snyder SH. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40: 129-137, 2003.
30. Boyle EM Jr., Kovacich JC, Hebert CA, Canty TG Jr., Chi E, Morgan EN, Pohlman TH, and Verrier ED. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 116: 114-121, 1998.
31. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
32. Brouet A, Sonveaux P, Dessy C, Balligand JL, and Feron O. Hsp90 ensures the transition from the early Ca2\+-dependent to the late phosphorylation- dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J Biol Chem 276: 32663-32669, 2001.
33. Brown SD and Piantadosi CA. In vivo binding of carbon monoxide to cytochrome c oxidase in rat brain. J Appl Physiol 68: 604-610, 1990.
34. Bussolati B and Mason JC. Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis. Antiox Redox Signal 8: 1153-1163, 2006.
35. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, and Mason JC. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761-766, 2004.
36. Calabrese V, Cornelius C, Dinkova-Kostova AT, and Ca-labrese EJ. Vitagenes, cellular stress response, and acet-ylcarnitine: relevance to hormesis. Biofactors 35: 146-160, 2009.
37. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, and Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33: 2444-2471, 2008.
38. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, and Butterfield DA. Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal 11: 2717-2739, 2009.
39. Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C, Butterfield DA, and Stella AG. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vita-genes. Neurochem Res 32: 757-773, 2007.
40. Calabrese V, Mancuso CM, Rizzarelli E, Butterfield DA, and Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8: 766-775, 2007.
41. Calabrese V, RavagnaA, Colombrita C, Guagliano E, Sca-pagnini G, Calvani M, Butterfield DA, Giuffrida Stella AM. Acetylcarnitine induces heme oxigenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J Neurosci Res 79: 509-521, 2005.
42. Camhi SL, Alam J, Otterbein L, Sylvester SL, and Choi AM. Induction of heme oxygenase-1 gene expression by lipo-polysaccharide is mediated by AP-1 activation. Am J Respir Cell Mol Biol 13: 387-398, 1995.
43. Cepinskas G, Katada K, Bihari A, and Potter RF. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 294: G184-G191, 2008.
44. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, and Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864, 2004.
45. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, and Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95: 11715-11720, 1998.
46. Chatterjee PK. Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the "silent killer." Br J Pharmacol 142: 391-393, 2004.
47. Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau C, Renaudin K, Tesson L, Soulillou JP, Iyer S, Buelow R, and Anegon I. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2: 581-592, 2002.
48. Chen JC, Huang KC, and Lin WW. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Signal 18: 32-39, 2006.
49. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, Joseph R, Cruz PE, Hauswirth WW, Madsen KM, Croker BP, Berns KI, Atkinson MA, Flotte TR, Tisher CC, and Agarwal A. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci USA 102: 7251-7256, 2005.
50. Chen SM, Li YG, and Wang DM. Study on changes of heme oxygenase-1 expression in patients with coronary heart disease. Clin Cardiol 28: 197-201, 2005.
51. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, Wasserman MA, Medford RM, Jaiswal AK, and Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278: 703-711, 2003.
52. Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, and Lin SJ. Heme oxygenase-1 gene promotor micro-satellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 25: 39-47, 2004.
53. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
54. Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, and Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 280: 41921-41927, 2005.
55. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, Gallo D, Cszimadia E, Bach FH, Lee PJ, and Otterbein LE. Hypoxia-inducible factor 1a stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA 104: 5109-5114, 2007.
56. Choi BM, Pae HO, Kim YM, and Chung HT. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology 37: 810-823, 2003.
57. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, and Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91: 3527-3561, 1998.
58. Coffman LG, Parsonage D, D'Agostino R, Jr., Torti FM, and Torti SV. Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci USA 106: 570-575, 2009.
59. Cross MJ and Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22: 201-207, 2001.
60. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, and Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115: 1789-1797, 2007.
61. Cvetanovic M and Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol 172: 880-889, 2004.
62. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, and Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50: 636-642, 2007.
63. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajava-shisth TB, Gimbrone MA Jr., Shin WS, and Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Investig 96: 60-68, 1995.
64. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capo-grossi MC, and Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482, 2004.
65. Deng YM, Wu BJ, Witting PK, and Stocker R. Probucol protects against smooth muscle cell proliferation by upre-gulating heme oxygenase-1. Circulation 110: 1855-1860, 2004.
66. Deramaudt BM, Braunstein S, Remy P, and Abraham NG. Gene transfer of human heme oxygenase-1 into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127, 1998.
67. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, and Agarwal A. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204: 605-618, 2007.
68. Dimmeler S, and Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 82: 671-677, 2004.
69. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, and Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693-698, 2001.
70. Dulak J, Deshane J, Jozkowicz A, and Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobi-ology: focus on angiogenesis. Circulation 117: 231-241, 2008.
71. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, and Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002.
72. Dulak J, Loboda A, and Jozkowicz A. Effect of heme oxy-genase-1 on vascular function and disease. Curr Opin Li-pidol 19: 505-512, 2008.
73. Durante W, Johnson FK, and Johnson RA. Role of carbon monoxide in cardiovascular function. J Cell Mol Med 10: 672-686, 2006.
74. Durante W, Kroll MH, Christodoulides N, Peyton KJ, and Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80: 557-564, 1997. (Pubitemid 27137293)
75. Elbirt KK, Whitmarsh AJ, Davis RJ, and Bonkovsky HL. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J Biol Chem 273: 8922-8931, 1998.
76. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, Jordanova N, Wojta J, Mannhalter C, Wagner OF, and Huber K. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 91: 155-161, 2004.
77. Erwig LP, Kluth DC, and Rees AJ. Macrophages in renal inflammation. Curr Opin Nephrol Hypertens 10: 341-347, 2001.
78. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, and Wagner O. Heme oxyge-nase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8: 433-440, 2001.
79. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, and Henson PM. Macrophages that have ingested apo-ptotic cells in vitro inhibit proinflammatory cytokine production through autocrine=paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890-898, 1998.
80. Fernandez M and Bonkovsky HL. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139: 634-640, 2003.
81. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW. Heterozygous embryonic lethality induced by targeted in-activation of the VEGF gene. Nature 380: 439-442, 1996.
82. Florczyk UM, Jozkowicz A, and Dulak J. Biliverdin re-ductase: new features of an old enzyme and its potential therapeutic significance. Pharmacol Rep 60: 38-48, 2008.
83. Foo RS, Siow RC, Brown MJ, and Bennett MR. Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy. J Cell Physiol 209: 1-7, 2006.
84. Foresti R and Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 31: 459-475, 1999.
85. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, and Motterlini R. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142: 453-460, 2004.
86. Fö rstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5: 338-349, 2008.
87. Freire-de-Lima, CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, DosReis GA, and Lopes MF. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199-203, 2000.
88. Fürst R, Blumenthal SB, Kiemer AK, Zahler S, and Vollmar AM. Nuclear factor-kappaB-independent anti-inflammatory action of salicylate in human endothelial cells: induction of heme oxygenase-1 by the c-Jun N-terminal kinase=activator protein-1 pathway. J Pharmacol Exp Ther 318: 389-394, 2006.
89. Fürst R, Brueckl C, Kuebler WM, Zahler S, Krötz F, Görlach A, Vollmar AM, and Kiemer AK. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxi-dase=Nox2-activation. Circ Res 96: 43-53, 2005.
90. Galkina E and Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27: 165-197, 2009.
91. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
92. Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, and Gottschall CA. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J 51: 86-91, 2010.
93. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, and Presta M. Distinct role of fibro-blast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162: 1913-1926, 2003.
94. Goodman AI, Quan S, Yang L, Synghal A, and Abraham NG. Functional expression of human heme oxygenase-1 gene in renal structure of spontaneously hypertensive rats. Exp Biol Med (Maywood) 228: 454-458, 2003.
95. Gordon, S. Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003.
96. Gozzelino R, Jeney V, and Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354, 2010.
97. Grochot-Przeczek A, Lach R, Mis J, Skrzypek K, Gozdecka M, Sroczynska P, Dubiel M, Rutkowski A, Kozakowska M, Zagorska A, Walczynski J, Was H, Kotlinowski J, Drukala J, Kurowski K, Kieda C, Herault Y, Dulak J, and Jozkowicz A. Heme oxygenase-1 accelerates cutaneous wound healing in mice. PLoS One 4: e5803, 2009.
98. Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkel-mann U, Smith G, and Schroder H. Rosuvastatin upregu-lates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun 325: 871-876, 2004.
99. Gueler F, Park JK, Rong S, Kirsch T, Lindschau C, Zheng W, Elger M, Fiebeler A, Fliser D, Luft FC, and Haller H. Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol 170: 1192-1199, 2007.
100. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, and Omata M. Blockade of the stromal cell-derived factor-1= CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65: 5864-5871, 2005.
101. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, and Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286: H1649-H1653, 2004.
102. Habeos IG, Ziros PG, Chartoumpekis D, Psyrogiannis A, Kyriazopoulou V, and Papavassiliou AG. Simvastatin activates Keap1=Nrf2 signaling in rat liver. J Mol Med 86: 1279-1285 2008.
103. Halliwell B and Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219: 1-14, 1984.
104. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, and Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
105. Heeba G, Moselhy ME, Hassan M, Khalifa M, Gryglewski R, and Malinski T. Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1., Br J Pharmacol,156, 1256-1266, 2009w
106. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, Sata M, Ichiki T, Takeshita A, and Egashira K. Gene transfer of stromal cell-derived factor-1 enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor=endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109: 2454-2461, 2004.
107. Hill-Kapturczak N, Chang SH, and Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol 21: 307-321, 2002.
108. Hu CM, Chen YH, Chiang MT, and Chau LY. Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 110: 309-316, 2004.
109. Huang LE, Willmore WG, Gu J, Goldberg MA, and Bunn HF. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem 274: 9038-9044, 1999.
110. Idriss NK, Blann AD, and Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 52: 971-978, 2008.
111. Igarashi K and Sun J. The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid Redox Signal 8: 107-118, 2006.
112. Ishikawa K, Navab M, Leitinger N, Fogelman AM, and Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216, 1997.
113. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, Itabe H, and Maruyama Y. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipi-demic rabbits. Circulation 104: 1831-1836, 2001.
114. Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe H, Maruyama Y, and Lusis AJ. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88: 506-512, 2001.
115. Ishizaka N, de Leon H, Laursen JB, Fukui T, Wilcox JN, De Keulenaer G, Griendling KK, and Alexander RW. Angio-tensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 96: 1923-1929, 1997.
116. Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, Logun C, Raghavachari N, Beigel JH, Shelhamer JH, Dan-ner RL, and Gladwin MT. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104: 270-280, 2004.
117. Johnson RA, Lavesa M, Askari B, Abraham NG, and Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25: 166-169, 1995.
118. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, and Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol 271: H1132-H1138, 1996.
119. Jones CI, 3rd, Han Z, Presley T, Varadharaj S, Zweier JL, Ilangovan G, and Alevriadou BR. Endothelial cell respiration is affected by the oxygen tension during shear exposure: role of mitochondrial peroxynitrite. Am J Physiol Cell Physiol 295: C180-C191, 2008.
120. Jozkowicz A, Cooke JP, Guevara I, Huk I, Funovics P, Pa-chinger O, Weidinger F, and Dulak J. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 51: 773-783, 2001.
121. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
122. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, and Chau LY. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001.
123. Kacimi R, Chentoufi J, Honbo N, Long CS, and Karliner JS. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 46: 139-150, 2000.
124. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, and Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22: 1680-1685, 2002.
125. Kapitulnik J, Maines MD. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotec-tive and cytotoxic bilirubin. Trends Pharmacol Sci 30: 129-137, 2009.
126. Kaspar JW, Niture SK, and Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47: 1304-1309, 2009.
127. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, and Maruyama Y. Bilir-ubin from heme oxygenase-1 attenuates vascular endothe-lial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
128. Kawashima A, Oda Y, Yachie A, Koizumi S, and Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33: 125-130, 2002.
129. Kemp PJ. Hemeoxygenase-2 as an O2 sensor in K\+ channel-dependent chemotransduction. Biochem Biophys Res Commun 338: 648-652 2005.
130. Kim HP, Ryter SW, and Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 46: 411-449, 2006.
131. Kim HP, Wang X, Zhang J, Suh GY, Benjamin IJ, Ryter SW, and Choi AM. Heat shock protein-70 mediates the cyto-protective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol 175: 2622-2629, 2005.
132. Kim JE, Kang YJ, Lee KY, and Choi HC. Isoproterenol inhibits angiotensin II-stimulated proliferation and reactive oxygen species production in vascular smooth muscle cells through heme oxygenase-1. Biol Pharm Bull 32: 1047-1052, 2009.
133. Kim KM, Pae HO, Zheng M, Park R, Kim YM, and Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 101: 919-927, 2007.
134. Kim YM, Bombeck CA, and Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84: 253-256, 1999.
135. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC, Pratt RE, and Dzau VJ. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109: 1769-1775, 2004.
136. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, and Leitinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-acti-vated receptors. Arterioscler Thromb Vasc Biol 27: 1276-1282, 2007.
137. Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, Shenouda S, Goodman AI, Goli-gorsky MS, Kappas A, and Abraham NG. Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 319: 1144-1152, 2006.
138. Lee PJ, Alam J, Wiegand GW, and Choi AM. Over-expression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci USA 93: 10393-10398, 1996.
139. Lee TS and Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240-246, 2002.
140. Lee TS, Chang CC, Zhu Y, and Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302, 2004.
141. Lerner-Marmarosh N, Miralem T, Gibbs PE, and Maines MD. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc Natl Acad Sci USA 105: 6870-6875, 2008.
142. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, and Stocker R. Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 9: 2227-2239, 2007.
143. Li Volti G, Wang J, Traganos F, Kappas A, and Abraham N. Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochem Biophys Res Commun 296: 1077-1082, 2002.
144. Liao JK, and Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118, 2005.
145. Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, and Chau LY. Heme oxygenase-1 promotes neovascularization in ische-mic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol 45: 44-55, 2008.
146. Lin HH, Chen YH, Yet SF, and Chau LY. Heme oxygenase-1=carbon monoxide enhances reendothelialization after vascular injury via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemost 7: 1401-1408, 2009.
147. Llesuy SF and Tomaro ML. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1223: 9-14, 1994.
148. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, and Dulak J. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 1767-1812, 2008.
149. Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, and Dulak J. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human micro-vascular endothelial cells. Atherosclerosis 187: 26-30, 2006.
150. Losordo DW, and Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation 109: 2487-2491, 2004. (Pubitemid 38720544)
151. Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, and Gibbs PE. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII. J Biol Chem 282: 8110-8122, 2007.
152. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
153. Mancuso C. Heme oxygenase and its products in the nervous system. Antioxid Redox Signal 6: 878-887, 2004.
154. Mancuso C and Barone E. The heme oxygenase=biliverdin reductase pathway in drug research and development. Curr Drug Metab 10: 579-594, 2009.
155. Mancuso C, Bonsignore A, Capone C, Di Stasio E, and Pani G. Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid Redox Signal 8: 487-494, 2006.
156. Mancuso C, Kostoglou-Athanassiou I, Forsling ML, Grossman AB, Preziosi P, Navarra P, and Minotti G. Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function. Brain Res Mol Brain Res 50: 267-276 1997.
157. Mancuso C, Pani G, and Calabrese V. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep 11: 207-213, 2006.
158. Mancuso C, Perluigi M, Cini C, De Marco C, Giuffrida Stella AM, and Calabrese V. Heme oxygenase and cy-clooxygenase in the central nervous system: a functional interplay. J Neurosci Res 84: 1385-1391, 2006.
159. Mancuso C, Pistritto G, Tringali G, Grossman AB, Preziosi P, and Navarra P. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypo-thalamic explants and in primary cultures of rat hypotha-lamic astrocytes. Brain Res Mol Brain Res 45: 294-300, 1997.
160. Mantovani A, Sozzani S, Locati M, Allavena P, and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002.
161. Marti HH and Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 95: 15809-15814, 1998.
162. McCoubrey WK, Jr., Huang TJ, and Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725-732, 1997.
163. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, and Kour-embanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98: 8798-8803, 2001.
164. Miralem T, Hu Z, Torno MD, Lelli KM, and Maines MD. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem 280: 17084-17092.
165. Mizuguchi S, Stephen J, Bihari R, Markovic N, Suehiro S, Capretta A, Potter RF, and Cepinskas G. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. Am J Physiol Heart Circ Physiol 297: H920-H929, 2009.
166. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, and Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346: 1773-1780, 2002.
167. Morita T, Perrella MA, Lee ME, and Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92: 1475-1479, 1995.
168. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25: 1786-1795, 2005.
169. Morse D and Sethi J. Carbon monoxide and human disease. Antioxid Redox Signal 4: 331-338, 2002.
170. Morse D, Lin L, Choi AM, and Ryter SW. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 47: 1-12, 2009.
171. Morsi WG, Shaker OG, Ismail EF, Ahmed HH, El-Serafi TI, Maklady FA, Abdel-Aziz MT, El-Asmar MF, and Atta HM. HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 39: 1057-1062, 2006.
172. Motohashi H and Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trend Mol Med 10: 549-557, 2004.
173. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, and Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-E24, 2002.
174. Motterlini R, Foresti R, Intaglietta M, and Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270: H107-H114, 1996.
175. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Drain PF, Sasidhar M, Nabel EG, Takahashi T, Lukacs NW, Ryter SW, Morita K, and Choi AM. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203: 2377-2389, 2006.
176. Nakao A, Kaczorowski DJ, Sugimoto R, Billiar TR, and McCurry KR. Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia=reperfusion injury. J Clin Biochem Nutr 42: 78-88, 2008.
177. Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F, Bach FH, Billiar TR, Choi AM, Otterbein LE, and Murase N. Protection against ischemia=reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5: 282-291, 2005.
178. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, and Hebbel RP. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893-903, 2001.
179. Ndisang JF and Jadhav A. The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. Am J Physiol Regul Integr Comp Physiol 298: R211-R223, 2010.
180. Ndisang JF and Jadhav A. Up-regulating the heme oxyge-nase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 150: 2627-2636, 2009.
181. Ndisang JF, Lane N, and Jadhav A. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 150: 2098-2108, 2009.
182. Ndisang JF, Lane N, Syed N, and Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 151: 549-560, 2010.
183. Ndisang JF, Tabien HE, and Wang R. Carbon monoxide and hypertension. J Hypertens 22: 1057-1074, 2004.
184. Ndisang JF, Wu L, Zhao W, and Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101: 3893-3900, 2003.
185. Ndisang JF, Zhao W, and Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 40: 315-321, 2002.
186. Nguyen T, Nioi P, and Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295, 2009.
187. Nizamutdinova IT, Kim YM, Kim HJ, Seo HG, Lee JH, and Chang KC. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells. Atherosclerosis 207: 405-411, 2009.
188. Ockaili, Ramzi, Ramesh Natarajan, Fadi Salloum, Bernard J. Fisher, Drew Jones, Alpha A. Fowler III, and Rakesh C. Kukreja. HIF-1 activation attenuates postischemic myocar-dial injury: role for heme oxygenase-1 in modulating mi-crovascular chemokine generation. Am J Physiol Heart Circ Physiol 289: H542-H548, 2005.
189. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, and Chung HT. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: 106-119, 2006.
190. Omura S, Suzuki H, Toyofuku M, Ozono R, Kohno N, and Igarashi K. Effects of genetic ablation of bach1 upon smooth muscle cell proliferation and atherosclerosis after cuff injury. Genes Cells 10: 277-285, 2005.
191. Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, and Iwai N. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 173: 315-319, 2004.
192. Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis AJ, and Araujo JA. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100: 1703-1711, 2007.
193. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
194. Otterbein LE, Soares MP, Yamashita K, and Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455, 2003.
195. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, and Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9: 183-190, 2003.
196. Pachori AS, Melo LG, Hart ML, Noiseux N, Zhang L, Morello F, Solomon SD, Stahl GL, Pratt RE, and Dzau VJ. Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia=reperfusion tissue injury. Proc Natl Acad Sci USA 101: 12282-12287, 2004.
197. Pae HO, Jeong GS, Kim HS, Woo WH, Rhew HY, Kim HS, Sohn DH, Kim YC, and Chung HT. Costunolide inhibits production of tumor necrosis factor-alpha and interleukin-6 by inducing heme oxygenase-1 in RAW264.7 macrophages. Inflamm Res 56: 520-526, 2007.
198. Pae HO, Kim EC, and Chung HT. Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J Clin Biochem Nutr 42: 197-203, 2008.
199. Pae HO, Lee YC, and Chung HT. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov 2: 159-165, 2008.
200. 2S) in inflammation. Arch Pharm Res 32: 1155-1162, 2009.
201. Pae HO, Oh GS, Choi BM, Kim YM, and Chung HT. A molecular cascade showing nitric oxide-heme oxygenase-1-vascular endothelial growth factor-interleukin-8 sequence in human endothelial cells. Endocrinology 146: 2229-2238, 2005.
202. Pae HO, Oh GS, Lee BS, Rim JS, Kim YM, and Chung HT. 3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis 187: 274-284, 2006.
203. Pan S. Molecular mechanisms responsible for the ather-oprotective effects of laminar shear stress. Antioxid Redox Signal 11: 1669-1682, 2009.
204. Papapetropoulos A, Garcia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the an-giogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
205. Paredi P, Biernacki W, Invernizzi G, Kharitonov SA, and Barnes PJ. Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest 116: 1007-1011, 1999.
206. Peterson SJ and Frishman WH. Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 17: 99-111, 2009.
207. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, Wang H, Schafer AI, and Durante W. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99: 4443-4448, 2002.
208. Ponka P. Cell biology of heme. Am J Med Sci 318: 241-256, 1999.
209. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
210. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94: 10925-10930, 1997.
211. Qi X, Li J, Gu J, Li S, Dang Y, and Wang T. Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. Jpn Heart J 44: 451-461, 2003.
212. Qing G and Simon MC. Hypoxia inducible factor-2: a critical mediator of aggressive tumor phenotypes. Curr Opin Genet Dev 19: 60-66, 2009.
213. Quan S, Yang L, Abraham NG, and Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci USA 98: 12203-12208, 2001.
214. Rathmell JC and Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 17: 781-828, 1999.
215. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355: 1274-1277, 2006.
216. Rouse BT. Regulatory T cells in health and disease. J Intern Med 262: 78-95, 2007.
217. Rucker M, Schafer T, Roesken F, Spitzer WJ, Bauer M, and Menger MD. Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. Surgery 129: 292-301, 2001.
218. Ryter SW, Alam J, and Choi AM. Heme oxygenase-1=carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006.
219. Ryter SW, Morse D, and Choi AM. Carbon monoxide and bilirubin: potential therapies for pulmonary=vascular injury and disease. Am J Respir Cell Mol Biol 36: 175-182, 2007.
220. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, and Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 38: 210-215, 2001.
221. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, and Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185-4194, 2001.
222. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Ham-brecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, and Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221, 2006. (Pubitemid 44427445)
223. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Ham-brecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, and Zeiher AM. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783, 2006.
224. Schaefer WH, Harris TM, and Guengerich FP. Characterization of the enzymatic and nonenzymatic peroxidative degradation of iron porphyrins and cytochrome P-450 heme. Biochemistry 24: 3254-3263, 1985.
225. Schwentker A and Billiar TR. Inducible nitric oxide syn-thase: from cloning to therapeutic applications. World J Surg 26: 772-778, 2002.
226. Schwer CI, Mutschler M, Stoll P, Goebel U, Humar M, Hoetzel A, and Schmidt R. Carbon monoxide releasing molecule-2 inhibits pancreatic stellate cell proliferation by activating p38 mitogen-activated protein kinase=heme oxygenase-1 signaling. Mol Pharmacol 77: 660-669, 2010.
227. Seldon MP, Silva G,PejanovicN,LarsenR,Gregoire IP, Filipe J, Anrather J, and Soares MP. Heme oxygenase-1 inhibits the expressionofadhesion molecules associated with endothelial cell activation via inhibition of NF-kB RelA phosphorylation at serine 276. J Immunol 179: 7840-7851, 2007.
228. Sellers KW, Katovich MJ, Gelband CH, and Raizada MK. Gene therapy to control hypertension: current studies and future perspectives. Am J Med Sci 322: 1-6, 2001.
229. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
230. Serbina NV and Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7: 311-317, 2006.
231. Seta F, Bellner L, Rezzani R, Regan RF, Dunn MW, Abraham NG, Gronert K, and Laniado-Schwartzman M. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol 169: 1612-1623, 2006.
232. Shakeri-Manesch S, Zeyda M, Huber J, Ludvik B, Prager G, and Stulnig TM. Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond) 33: 1257-1264, 2009.
233. Shibahara S. The heme oxygenase dilemma in cellular ho-meostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med 200: 167-186, 2003.
234. Shibuya M. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep 41: 278-286, 2008.
235. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG, Elias JA, and Lee PJ. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J 21: 1422-1432, 2007.
236. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, and Bach FH. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073-1077, 1998.
237. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, and Bach FH. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172: 3553-3563, 2004.
238. Sodhi K, Inoue K, Gotlinger KH, Canestraro M, Vanella L, Kim DH, Manthati VL, Koduru SR, Falck JR, Schwartzman ML, and Abraham NG. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 331: 906-916, 2009.
239. Song H, Bergstrasser C, Rafat N, Höger S, Schmidt M, Endres N, Goebeler M, Hillebrands JL, Brigelius-Flohé R, Banning A, Beck G, Loesel R, and Yard BA. The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression. Br J Pharmacol 157: 769-780, 2009.
240. Song R, Mahidhara RS, Liu F, Ning W, Otterbein LE, and Choi AM. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol 27: 603-610, 2002.
241. Sonveaux P, Jordan BF, Gallez B, and Feron O. Nitric oxide delivery to cancer: why and how? Eur J Cancer 45: 1352-1369, 2009.
242. Sorrenti V, Mazza F, Campisi A, Di Giacomo C, Acquaviva R, Vanella L, and Galvano F. Heme oxygenase induction by cyanidin-3-O-beta-glucoside in cultured human endothelial cells. Mol Nutr Food Res 51: 580-586, 2007.
243. Srisook K, Han SS, Choi HS, Li MH, Ueda H, Kim C, and Cha YN. CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem Pharmacol 71: 307-318, 2006.
244. Stec DE, Drummond HA, and Vera T. Role of carbon monoxide in blood pressure regulation. Hypertension 51: 597-604, 2008.
245. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 6: 841-849.
246. Stocker R and Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114: 2178-2189, 2006.
247. Stone JR and Marletta MA. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon mon-oxide and spectral characterization of the ferrous and ferric states. Biochemistry, 33, 5636-5640, 1994.
248. Sun X, Pi J, Liu W, Hudson LG, Liu KJ, and Feng C. Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells. Toxicol Appl Pharmacol 236: 202-209, 2009.
249. Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gabrielson KL, Polotsky VY, and Biswal S. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS One 3: e3791, 2008.
250. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, Sato T, Ohno M, Nagai R, and Ishizaka N. Facilitated angio-genesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143, 2003.
251. Sylvester JT and McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vaso-constriction. Circ Res 43: 429-437, 1978.
252. Szabo ME, Gallyas E, Bak I, Rakotovao A, Boucher F, de Leiris J, Nagy N, Varga E, and Tosaki A. Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic= reperfused rat retina. Invest Ophthalmol Vis Sci 45: 3727-3732, 2004.
253. Taille C, Almolki A, Benhamed M, Zedda C, Megret J, Berger P, Leseche G, Fadel E, Yamaguchi T, Marthan R, Aubier M, and Boczkowski J. Heme oxygenase inhibits human airway smooth muscle proliferation via a bilirubin-dependent modulation of ERK1=2 phosphorylation. J Biol Chem 278: 27160-27168, 2003.
254. Taille C, El-Benna J, Lanone S, Boczkowski J, and Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280: 25350-25360, 2005.
255. Tanaka M, Fukui M, Tomiyasu K, Akabame S, Nakano K, Hasegawa G, Oda Y, and Nakamura N. Low serum bili-rubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis 206: 287-291, 2009.
256. Tang LM, Wang YP, Wang K, Pu LY, Zhang F, Li XC, Kong LB, Sun BC, Li GQ, and Wang XH. Exogenous biliverdin ameliorates ischemia-reperfusion injury in small-for-size rat liver grafts. Transplant Proc 39: 1338-1344, 2007.
257. Tang YL, Qian K, Zhang YC, Shen L, and Phillips MI. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 10: 251-263, 2005.
258. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, and Phillips MI. Improved graft mesenchymal stem cell survival in is-chemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350, 2005.
259. Tedgui A and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581, 2006.
260. Terry CM, Clikeman JA, Hoidal JR, and Callahan KS. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol 274: H883-H891, 1998.
261. Thom SR, Fisher D, Xu YA, Notarfrancesco K, and Ishir-opoulos H. Adaptive responses and apoptosis in cells exposed to carbon monoxide. Proc Natl Acad Sci USA 97: 1305-1310, 2000.
262. Thorup C, Jones CL, Gross SS, Moore LC, and Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol, 277, F882-F889, 1999.
263. Tobiasch E, Günther L, and Bach FH. Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J Invest Med 49: 566-571, 2001.
264. Tongers J, Knapp JM, Korf M, Kempf T, Limbourg A, Limbourg FP, Li Z, Fraccarollo D, Bauersachs J, Han X, Drexler H, Fiedler B, and Wollert KC. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice. Cardiovasc Res 78: 294-300, 2008.
265. Tranter M, Jones WK. Anti-inflammatory effects of HO-1 activity in vascular endothelial cells, commentary on "Carbon monoxide donors or heme oxygenase (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death." Free Radic Biol Med 44: 261-263, 2008.
266. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, and Charo IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin In-vestig 117: 902-909, 2007.
267. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, and Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104: 2710-2715, 2001.
268. Vachharajani TJ, Work J, Issekutz AC, and Granger DN. Heme oxygenase modulates selectin expression in different regional vascular beds.AmJ Physiol 278: H1613-H1617, 2000.
269. Van Belle E, Bauters C, Asahara T, and Isner JM. En-dothelial regrowth after arterial injury: From vascular repair to therapeutics. Cardiovasc Res 38: 54-68, 1998.
270. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, and Agarwal A. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107: 911-916, 2003.
271. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, and Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351, 1997.
272. Wagener FADTG, Da Silva J-L, Farley T, de Witte T, Kappas A, Abraham NG. Differential effects of heme oxygenase isoforms on heme-mediated endothelial ICAM-1 expression. J Pharmacol Exp Ther 291: 416-423, 1999.
273. Wagener FADTG, Feldman E, Witte de T, and Abraham NG. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1 and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med 216: 456-463, 1997.
274. Wang LJ, Lee TS, Lee FY, Pai RC, and Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720, 1998.
275. Wang R and Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272: 8222-8226, 1997. (Pubitemid 27147775)
276. Wang R, Wu L, and Wang Z. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 434: 285-291, 1997. (Pubitemid 27276232)
277. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, and Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 282: 1718-1726, 2007.
278. Wang XM, Kim HP, Nakahira K, Ryter SW, and Choi AM. The heme oxygenase-1=carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 182: 3809-3818, 2009.
279. Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratajska A, Kieda C, Szala S, Dulak J, and Jozkowicz A. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 169: 2181-2198, 2006.
280. Watson T, Goon PK, and Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal 10: 1079-1088, 2008.
281. Weis N, Weigert A, von Knethen A, and Brone B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell 20: 1280-1288, 2009.
282. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, and Moore PK. Evidence for the formation of a novel ni-trosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 343: 303-310, 2006.
283. Wilson HM, Walbaum D, and Rees AJ. Macrophages and the kidney. Curr Opin Nephrol Hypertens 13: 285-290, 2004.
284. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, and Stocker R. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203: 1117-1127, 2006.
285. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, Gamble JR, and Stocker R. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29: 1537-1542, 2009.
286. Wu L and Juurlink BH. Increased methylglyoxal and oxi-dative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39: 809-814, 2002.
287. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
288. Yachie A, Toma T, Mizuno K, Okamoto H, Shimura S, Ohta K, Kasahara Y, and Koizumi S. Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illnesses of children. Exp Biol Med 228: 550-556, 2003.
289. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, and Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328, 2003.
290. Yamaguchi M, Sato H, and Bannai S. Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochem Biophys Res Commun 193: 1198-1201, 1993. (Pubitemid 23209721)
291. Yamaya M, Sekizawa K, Ishizuka S, Monma M, and Sasaki H. Exhaled carbon monoxide levels during treatment of acute asthma. Eur Respir J 13: 757-760, 1999.
292. Yee EL, Pitt BR, Billiar TR, and Kim YM. Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells. Am J Physiol 271: L512-L518, 1996.
293. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, and Perrella MA. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759-1761, 2003.
294. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, and Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest, 103, R23-R29, 1999.
295. Yoshida T, Maulik N, Ho YS, Alam J, and Das DK. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 103: 1695-1701, 2001.
296. Yoshinaga T, Sassa S, and Kappas A. A comparative study of heme degradation by NADPH-cytochrome c reductase alone and by the complete heme oxygenase system. Distinctive aspectsofheme degradationbyNADPH-cytochrome c reductase. J Biol Chem 257: 7794-7802, 1982.
297. Zabalgoitia M, Colston JT, Reddy SV, Holt JW, Regan RF, Stec DE, Rimoldi JM, Valente AJ, and Chandrasekar B. Carbon monoxide donors or heme oxygenase (HO-1) over-expression blocks interleukin-18-mediated NF-kB-PTEN-dependent human cardiac endothelial cell death. Free Radic Biol Med 44: 284-298, 2008.
298. Zhang S, Lu S, Ge J, Guo J, Chen P, Li T, Zhang P, Jia Z, Ma K, Liu Y, Zhou C, and Li L. Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation. Microvasc Res 69: 64-70, 2005.
299. Zhang X, Shan P, Alam J, Fu XY, and Lee PJ. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase=Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 280: 8714-9721, 2005.
300. Zuckerbraun BS, Chin BY, Bilban M, d'Avila JC, Rao J, Billiar TR, and Otterbein LE. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mi-tochondrial reactive oxygen species. FASEB J 21: 1099-1106, 2007.